Instytut Genetyki i Immunologii GENIM Spzoo

Lublin 20-609

0 studies enrolling now · 4 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, KRAS p, G12c Mutated /Advanced Metastatic NSCLC, Squamous-Cell Non-Small-Cell Lung Cancer

Studies at this site

• A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung Cancer — Running, not enrolling
• Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200). — Completed
• A Study of Combination Therapy With Amivantamab and Cetrelimab in Participants With Metastatic Non-small Cell Lung Cancer — Running, not enrolling
• A Study of Bemarituzumab Monotherapy and Combination With Other Anti-cancer Therapy in SqNSCLC With FGFR2b Overexpression (FORTITUDE-201) — Stopped early